Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/25 19:22 | 8/11/25 | CORT | Health | Drug | Pharmaceutical Preparations | Swisher Daniel N Jr | CA | D | 3 | S.d | -471 | 71.33 | 0 | -7 | -100 | 0 | D | |||||||||||||||
8/12/25 19:19 | 8/8/25 | CORT | Health | Drug | Pharmaceutical Preparations | Guyer William | CA | O | Chief De | 6 | S.dm | -6,721 | 72.84 | 0 | -92 | 5 | D | |||||||||||||||
8/5/25 18:51 | 8/1/25 | CORT | Health | Drug | Pharmaceutical Preparations | Maduck Sean | CA | O | See Rema | 4 | S.dm | -4,322 | 72.03 | 0 | -60 | 117 | M | |||||||||||||||
8/5/25 18:51 | 8/1/25 | CORT | Health | Drug | Pharmaceutical Preparations | Belanoff Joseph K | CA | DO | CEO | 3 | S | -6,101 | 75.68 | 0 | -81 | 2,902 | I | |||||||||||||||
8/5/25 18:47 | 8/1/25 | CORT | Health | Drug | Pharmaceutical Preparations | Lyon Joseph Douglas | CA | O | See Rema | 4 | S.dm | -1,090 | 72.68 | 0 | -15 | 10 | D | |||||||||||||||
6/18/25 18:26 | 6/16/25 | CORT | Health | Drug | Pharmaceutical Preparations | Robb Gary Charles | CA | O | Chief Bu | 2 | S | -398 | 72.89 | 0 | -5 | 37 | D | |||||||||||||||
5/20/25 19:13 | 5/16/25 | CORT | Health | Drug | Pharmaceutical Preparations | Mahoney David L | CA | D | 1 | S.d | -2,030 | 74.23 | 0 | -27 | 1,259 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |